Prognostic value of RASD1 transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia

Prognostic value of RASD1 transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia
复制标题

RASD1 转录水平在成人费城阴性 B 细胞急性淋巴细胞白血病中的预后价值

DOI:
10.1080/16078454.2020.1860359
复制
发表时间:
2020-12
期刊:
影响因子:
1.9
通讯作者:
Huang Xiao-Jun
Huang Xiao-Jun
中科院分区:
医学4区
文献类型:
--
作者:
Lu Run-Qing;Wu Li-Xin;Zhang Jing;Qin Ya-Zhen;Liu Yan-Rong;Lai Yue-Yun;Jiang Hao;Chang Ying-Jun;Ruan Guo-Rui;Huang Xiao-Jun

文献摘要

参考文献

相似文献

摘要目的Ras相关的地塞米松诱导1(RASD 1)在许多实体癌中异常表达。然而,其在成人B细胞急性淋巴细胞白血病(B-ALL)中的潜在作用尚不清楚。因此,我们的目的是阐明肿瘤相关生物标志物RASD 1的异常表达,作为诊断和预后成人费城阴性B-ALL的潜在靶点。方法采用RT-qPCR方法检测92例初发Ph阴性B-ALL患者和40例健康对照者RASD 1的表达。评估RASD 1转录水平与复发之间的相关性。结果Ph阴性B-ALL患者RASD 1基因表达水平(中位数81.76%,0.22%~ 1824.52%)显著高于健康对照组(中位数7.59%,0.46%~ 38.66%)(P<0.0001)。RASD 1转录水平低的患者5年无复发生存率较低(RFS,47.5% [32.9%,62.1%] vs. 63.1% [49.0%,77.2%]; P = 0.012)和更高的5年累积复发率(CIR,52.0% [37.4%,66.6%] vs. 36.2% [22.2%,50.2%]; P = 0.013),尤其是在仅接受化疗的患者中。多因素分析显示,低RASD 1转录水平是Ph阴性B-ALL患者RFS(HR = 2.938 [1.427,6.047],P = 0.003)和CIR(HR = 3.367 [1.668,6.796],P = 0.001)的独立危险因素。结论Ph阴性B-ALL患者RASD 1转录水平显著升高,低RASD 1转录水平与复发风险增加独立相关。
ABSTRACT Objectives Ras-related dexamethasone-induced 1 (RASD1) is abnormally expressed in many solid cancers. However, its potential role in adults with B-cell acute lymphoblastic leukemia (B-ALL) is unclear. Therefore, we aim to clarify the abnormal expression of the tumor-associated biomarker, RASD1, as a potential target for diagnosis and prognosis in adult Philadelphia-negative B-ALL. Methods The expression of RASD1 was detected with RT-qPCR in 92 adults with de novo Ph-negative B-ALL and 40 healthy controls. The correlation between RASD1 transcript levels and relapse was assessed. Results RASD1 transcript levels in patients with Ph-negative B-ALL (median 81.76%, range 0.22%-1824.52%) were significantly higher than those in healthy controls (7.59%, 0.46%-38.66%; P<0.0001). Patients with low RASD1 transcript levels had a lower 5-year relapse-free survival (RFS, 47.5% [32.9%, 62.1%] vs. 63.1% [49.0%, 77.2%]; P = 0.012) and a higher 5-year cumulative incidence of relapse (CIR, 52.0% [37.4%, 66.6%] vs. 36.2% [22.2%, 50.2%]; P = 0.013) especially in patients receiving chemotherapy only. Multivariate analysis showed that a low RASD1 transcript level was an independent risk factor for RFS (HR = 2.938 [1.427, 6.047], P = 0.003) and CIR (HR = 3.367 [1.668, 6.796], P = 0.001) in patients with Ph-negative B-ALL. Conclusions RASD1 transcript levels were significantly higher in patients with Ph-negative B-ALL and a low RASD1 transcript level was independently correlated with increased relapse risk.
复发/难治性多发性骨髓瘤中 RAS 信号传导的频繁功能激活不能用 RAS/RAF 突变来解释
DOI: 10.1038/s41598-018-31820-9
发表时间: 2018-09-10
期刊: Scientific reports
影响因子: 4.6
作者:
Wong KY;Yao Q;Yuan LQ;Li Z;Ma ESK;Chim CS
通讯作者: Chim CS
RASD1 过表达抑制胶质瘤细胞迁移/侵袭并失活 AKT/mTOR 信号通路
DOI: 10.1038/s41598-017-03612-0
发表时间: 2017-06-09
期刊: Scientific reports
影响因子: 4.6
作者:
Gao S;Jin L;Liu G;Wang P;Sun Z;Cao Y;Shi H;Liu X;Shi Q;Zhou X;Yu R
通讯作者: Yu R
DOI: 10.18632/oncotarget.4347
发表时间: 2015-09-22
期刊: Oncotarget
影响因子: --
作者:
O'Neill D;Jones D;Wade M;Grey J;Nakjang S;Guo W;Cork D;Davies BR;Wedge SR;Robson CN;Gaughan L
通讯作者: Gaughan L
DOI: 10.1186/s12885-016-2300-7
发表时间: 2016-04-11
期刊: BMC cancer
影响因子: 3.8
作者:
Yao QM;Liu KY;Gale RP;Jiang B;Liu YR;Jiang Q;Jiang H;Zhang XH;Zhang MJ;Chen SS;Huang XJ;Xu LP;Ruan GR
通讯作者: Ruan GR
富含半胱氨酸和甘氨酸的蛋白 2 (CSRP2) 转录水平与 B 细胞急性淋巴细胞白血病和细胞遗传学正常的成人患者的白血病复发和无白血病生存相关。
DOI: 10.18632/oncotarget.16416
发表时间: 2017-05-30
期刊: Oncotarget
影响因子: --
作者:
Wang SJ;Wang PZ;Gale RP;Qin YZ;Liu YR;Lai YY;Jiang H;Jiang Q;Zhang XH;Jiang B;Xu LP;Huang XJ;Liu KY;Ruan GR
通讯作者: Ruan GR